Dr. Yelin has received research support from Amgen (formerly Immunex) prior to 2004 and Aspreva.
Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study
Article first published online: 26 JUN 2014
Copyright © 2014 by the American College of Rheumatology
Arthritis Care & Research
Volume 66, Issue 7, pages 980–989, July 2014
How to Cite
Yelin, E., Tonner, C., Kim, S. C., Katz, J. N., Ayanian, J. Z., Brookhart, M. A. and Solomon, D. H. (2014), Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study. Arthritis Care Res, 66: 980–989. doi: 10.1002/acr.22244
- Issue published online: 26 JUN 2014
- Article first published online: 26 JUN 2014
- Accepted manuscript online: 10 DEC 2013 02:32PM EST
- Manuscript Accepted: 26 NOV 2013
- Manuscript Received: 9 SEP 2013
- NIH. Grant Number: R01-AR-056215
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Multidisciplinary Clinical Research Center. Grant Number: P60-A-053308
- NIH. Grant Number: K23-AR-059677
- Agency for Healthcare Research and Quality
- National Institute on Aging. Grant Numbers: R01-AG-023178, R01-AG-042845
- Patient-Centered Outcomes Research Institute (funding announcement 12001)
- NIH. Grant Numbers: K24-AR-055989, and P60-AR-047782
- 22012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625–39., , , , , , et al.
- 16Center for the Evaluative Clinical Sciences at Dartmouth Medical School.Dartmouth Atlas of Health Care.Lebanon (NH):Dartmouth Medical School;2004.
- 17U.S. Bureau of the Census.Design and methodology: American Community Survey.Washington, DC:U.S. Government Printing Office;2009.